Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.70
+1.84 (8.42%)
Nov 6, 2026, 4:00 PM EST - Market closed
Damora Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $60 → $59 | Buy | Maintains | $60 → $59 | +148.95% | Nov 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +68.78% | Nov 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $51 | Buy | Maintains | $51 | +115.19% | Nov 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $40 | Buy | Maintains | $40 | +68.78% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +89.87% | Nov 5, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $45 | Buy | Maintains | $45 | +89.87% | Sep 18, 2026 |
| Jefferies | Jefferies | Buy Maintains $50 | Buy | Maintains | $50 | +110.97% | Aug 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 11, 2026 |